Innovations Spur Medtech Investments

Robotic arm

In a new subsector report presented at the Northeast MedTech Summit in Boston, which was organized by SVB, SVB analyzed the investment and M&A activity of private, venture-backed medtech companies. Investment is poised to surpass 2016 levels, driven in part by two recent developments: monitoring devices that help expand care beyond traditional healthcare settings and advancements in neuromodulation.

Here are some additional insights you’ll glean from the subsector report:  

  • Device investing in 2017 is on track to surpass 2016, approaching its historical share of overall invested venture dollars
  • Early-stage medtech investing in 2017 is set to exceed 2016 in both the number of deals and the number of dollars invested
  • Corporate venture funds continue to play a central role in the landscape of medtech investors, with increasing participation from private equity firms and family offices
  • Strong investment in medtech technologies based on artificial intelligence and robotics suggests that the sector is poised to have a transformational impact on healthcare
  • The M&A environment for medtech remains robust, and the difference in exit multiples in favor of premarket approval and de novo 510(k) regulatory pathways continues

Download the full report to learn more.

About the Author

Bill Sideris is a Vice President with SVB’s northeast Medical Device and HealthTech practice, where he provides comprehensive financial products and services as well as flexible lending solutions to clients at every stage of development. Previous to this role, he was part of SVB Securities, performing valuations and advising Healthcare and Life Sciences clients on their M&A strategy. Prior to joining SVB, Bill spent time as an R&D Engineer, developing medical devices for ophthalmic and cardiovascular indications in both Fortune 500 and start-up organizations.

Bill graduated with a Professional Doctorate degree in engineering from the Technical University of Delft and a Master of Science degree in biomedical engineering from the University of Houston.